关键词

特定益生菌株；溃疡性结肠炎；黏膜愈合；免疫调节；作用机制

全文

PDF

参考

[1] Sartor, R. B. (2008). Microbial influences in inflammatory bowel diseases. Gastroenterology, 134(2), 577-594.

[2] Gevers, D., Kugathasan, S., Denson, L. A., et al. (2014). The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe, 15(3), 382-392.

[3] Bermúdez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., et al. (2012). Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Antonie Van Leeuwenhoek, 101(1), 1-24.

[4] Oelschlaeger, T. A. (2010). Mechanisms of probiotic actions--a review. Int J Med Microbiol, 300(1), 57-62.

[5] Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., et al. (2019). ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol, 114(3), 384-413.

[6] Sandborn, W. J., Feagan, B. G., Marano, C. W., et al. (2014). Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology, 146(1), 85-95.

[7] Sood, A., Midha, V., Makharia, G. K., et al. (2009). The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol, 7(11), 1202-1209.

[8] Kedia, S., Sood, A., Paul, R., et al. (2014). Efficacy of probiotic VSL#3 in the treatment of ulcerative colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Indian J Gastroenterol, 33(1), 20-25.